Increased immunoreactivity with anti-apoA-I or anti-SR-BI antibodies, but not immunoreactivity with anti-apoB antibodies, significantly differentiated 175 ccRCC tissues from papillary RCC (Table 1). The gene discussed is APOA1; the disease is nonpapillary renal cell carcinoma.